 Lauren Vanderlinden
Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Drinking | 6 | 2018 | 649 | 1.160 |
Why?
| | Rats, Inbred Strains | 4 | 2019 | 377 | 0.700 |
Why?
| | Quantitative Trait Loci | 5 | 2020 | 325 | 0.700 |
Why?
| | Quantitative Trait, Heritable | 2 | 2017 | 119 | 0.590 |
Why?
| | Gene Regulatory Networks | 4 | 2019 | 238 | 0.580 |
Why?
| | Darkness | 1 | 2015 | 22 | 0.500 |
Why?
| | DNA Methylation | 4 | 2020 | 512 | 0.480 |
Why?
| | Brain | 7 | 2017 | 2381 | 0.460 |
Why?
| | Alcoholism | 3 | 2014 | 716 | 0.450 |
Why?
| | Circadian Rhythm | 1 | 2015 | 392 | 0.390 |
Why?
| | Genetic Predisposition to Disease | 5 | 2020 | 2227 | 0.380 |
Why?
| | Phenotype | 2 | 2015 | 2892 | 0.350 |
Why?
| | Systems Biology | 2 | 2019 | 57 | 0.310 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2020 | 3361 | 0.230 |
Why?
| | Ethanol | 2 | 2018 | 566 | 0.230 |
Why?
| | Mice, Inbred Strains | 2 | 2015 | 404 | 0.220 |
Why?
| | Rats | 9 | 2019 | 5172 | 0.220 |
Why?
| | Metabolomics | 4 | 2020 | 541 | 0.220 |
Why?
| | Adiposity | 2 | 2017 | 509 | 0.210 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1588 | 0.200 |
Why?
| | Lipid Metabolism | 3 | 2019 | 467 | 0.200 |
Why?
| | Oxylipins | 1 | 2020 | 28 | 0.180 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 16 | 0.180 |
Why?
| | Anthracenes | 1 | 2019 | 27 | 0.170 |
Why?
| | Animals | 14 | 2020 | 32741 | 0.170 |
Why?
| | Genotype | 2 | 2015 | 1854 | 0.170 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 97 | 0.170 |
Why?
| | Eicosanoids | 1 | 2019 | 57 | 0.170 |
Why?
| | Fluorenes | 1 | 2019 | 37 | 0.160 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 8 | 0.160 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 110 | 0.160 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 101 | 0.160 |
Why?
| | Phthalic Acids | 1 | 2018 | 28 | 0.150 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 35 | 0.150 |
Why?
| | Transcriptome | 3 | 2018 | 756 | 0.150 |
Why?
| | Fatty Acids | 2 | 2017 | 398 | 0.150 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2017 | 5 | 0.150 |
Why?
| | GABA Modulators | 1 | 2017 | 9 | 0.150 |
Why?
| | Male | 17 | 2020 | 56700 | 0.150 |
Why?
| | CD24 Antigen | 1 | 2017 | 21 | 0.150 |
Why?
| | Genetic Association Studies | 2 | 2020 | 350 | 0.150 |
Why?
| | Multifactorial Inheritance | 1 | 2018 | 141 | 0.140 |
Why?
| | Seizures | 1 | 2020 | 347 | 0.140 |
Why?
| | Islets of Langerhans | 2 | 2020 | 729 | 0.140 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 88 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2018 | 141 | 0.140 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 334 | 0.140 |
Why?
| | Voltage-Gated Sodium Channels | 1 | 2016 | 4 | 0.140 |
Why?
| | Diet | 2 | 2020 | 1128 | 0.140 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 179 | 0.140 |
Why?
| | Food Hypersensitivity | 1 | 2020 | 260 | 0.130 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 84 | 0.130 |
Why?
| | Hippocampus | 1 | 2020 | 710 | 0.130 |
Why?
| | Quinolines | 1 | 2016 | 128 | 0.130 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 15 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 455 | 0.120 |
Why?
| | Birth Weight | 1 | 2017 | 466 | 0.120 |
Why?
| | Microarray Analysis | 1 | 2015 | 119 | 0.120 |
Why?
| | Obesity | 2 | 2017 | 2661 | 0.120 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2017 | 200 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 184 | 0.120 |
Why?
| | Neuralgia | 1 | 2016 | 122 | 0.120 |
Why?
| | Principal Component Analysis | 1 | 2015 | 181 | 0.120 |
Why?
| | Cell Nucleus | 1 | 2017 | 572 | 0.120 |
Why?
| | Genetic Variation | 1 | 2019 | 900 | 0.110 |
Why?
| | Behavior, Addictive | 1 | 2014 | 77 | 0.110 |
Why?
| | Female | 14 | 2020 | 60672 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2020 | 2038 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 354 | 0.110 |
Why?
| | Neurons | 2 | 2020 | 1311 | 0.110 |
Why?
| | Mice | 5 | 2017 | 15311 | 0.110 |
Why?
| | Species Specificity | 1 | 2014 | 561 | 0.110 |
Why?
| | Insulin | 2 | 2020 | 2135 | 0.110 |
Why?
| | Choice Behavior | 1 | 2014 | 160 | 0.110 |
Why?
| | Adenylyl Cyclases | 1 | 2012 | 84 | 0.110 |
Why?
| | Pediatrics | 1 | 2020 | 979 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 805 | 0.110 |
Why?
| | Gene Expression | 1 | 2017 | 1466 | 0.110 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2012 | 72 | 0.100 |
Why?
| | Placenta | 1 | 2018 | 628 | 0.100 |
Why?
| | Ibuprofen | 1 | 2012 | 75 | 0.100 |
Why?
| | Autoantibodies | 1 | 2019 | 1333 | 0.100 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 122 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 4 | 2020 | 2321 | 0.100 |
Why?
| | Lipocalin 1 | 1 | 2011 | 2 | 0.100 |
Why?
| | Blastocyst | 1 | 2011 | 44 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1053 | 0.090 |
Why?
| | Base Sequence | 1 | 2015 | 2123 | 0.090 |
Why?
| | Culture Media | 1 | 2011 | 157 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2017 | 514 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2012 | 158 | 0.090 |
Why?
| | Aneuploidy | 1 | 2011 | 88 | 0.090 |
Why?
| | Models, Genetic | 1 | 2013 | 587 | 0.090 |
Why?
| | Liver | 1 | 2018 | 1745 | 0.090 |
Why?
| | Postpartum Period | 1 | 2012 | 274 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2817 | 0.090 |
Why?
| | Autoimmunity | 3 | 2020 | 829 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2017 | 2236 | 0.090 |
Why?
| | Depressive Disorder, Major | 1 | 2012 | 304 | 0.090 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 166 | 0.090 |
Why?
| | Sex Factors | 1 | 2015 | 1758 | 0.080 |
Why?
| | Extracellular Matrix | 1 | 2012 | 446 | 0.080 |
Why?
| | Infant | 5 | 2020 | 8134 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2020 | 3099 | 0.080 |
Why?
| | Genome-Wide Association Study | 1 | 2014 | 1314 | 0.080 |
Why?
| | Asthma | 1 | 2020 | 2156 | 0.070 |
Why?
| | Rats, Inbred BN | 2 | 2018 | 53 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2014 | 2632 | 0.070 |
Why?
| | Humans | 17 | 2020 | 117098 | 0.070 |
Why?
| | Pregnancy | 4 | 2020 | 5654 | 0.070 |
Why?
| | Child, Preschool | 4 | 2020 | 9323 | 0.070 |
Why?
| | Signal Transduction | 1 | 2019 | 4606 | 0.070 |
Why?
| | Proteomics | 1 | 2011 | 844 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 546 | 0.060 |
Why?
| | Child | 5 | 2020 | 18881 | 0.060 |
Why?
| | Up-Regulation | 2 | 2019 | 837 | 0.050 |
Why?
| | Seroconversion | 1 | 2020 | 45 | 0.050 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 31 | 0.040 |
Why?
| | HLA-DR4 Antigen | 1 | 2020 | 75 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2020 | 77 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 2 | 2012 | 418 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 125 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 46 | 0.040 |
Why?
| | Chimera | 1 | 2019 | 59 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 334 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2020 | 121 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 14 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 507 | 0.040 |
Why?
| | Rats, Inbred SHR | 1 | 2018 | 42 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 221 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 163 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 110 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 258 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 238 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 36 | 0.040 |
Why?
| | Radioligand Assay | 1 | 2017 | 45 | 0.040 |
Why?
| | Electron Transport | 1 | 2017 | 96 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 423 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 128 | 0.040 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.040 |
Why?
| | Carnitine | 1 | 2017 | 65 | 0.040 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 47 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1105 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2019 | 793 | 0.040 |
Why?
| | Umbilical Cord | 1 | 2017 | 84 | 0.040 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 79 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 348 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2017 | 125 | 0.040 |
Why?
| | Muscle Development | 1 | 2017 | 102 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 396 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2017 | 5181 | 0.040 |
Why?
| | Risk Factors | 2 | 2020 | 8875 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 207 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 152 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 286 | 0.030 |
Why?
| | Sodium Channel Blockers | 1 | 2016 | 23 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1183 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 97 | 0.030 |
Why?
| | CHO Cells | 1 | 2016 | 142 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 259 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 453 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 158 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 653 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 860 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 34 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 345 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1590 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 730 | 0.030 |
Why?
| | Software | 1 | 2019 | 557 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 2015 | 172 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 910 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 833 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2015 | 392 | 0.030 |
Why?
| | Biomarkers | 2 | 2017 | 3551 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1206 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 460 | 0.030 |
Why?
| | Lipids | 1 | 2017 | 584 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 626 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1208 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2670 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2468 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1681 | 0.030 |
Why?
| | Basement Membrane | 1 | 2012 | 30 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 456 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 37 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2017 | 732 | 0.030 |
Why?
| | Laminin | 1 | 2012 | 70 | 0.030 |
Why?
| | Young Adult | 2 | 2018 | 10680 | 0.030 |
Why?
| | Models, Molecular | 1 | 2017 | 1405 | 0.030 |
Why?
| | Mitochondria | 1 | 2017 | 775 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 168 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 472 | 0.020 |
Why?
| | RNA | 1 | 2017 | 827 | 0.020 |
Why?
| | Mothers | 1 | 2017 | 682 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2012 | 130 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1148 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1040 | 0.020 |
Why?
| | Embryo Culture Techniques | 1 | 2011 | 12 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 472 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2481 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4507 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2017 | 1730 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 322 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1619 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2070 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4510 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3391 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 350 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4663 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 798 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6240 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 6391 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2408 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2433 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4124 | 0.020 |
Why?
| | Adult | 2 | 2018 | 31014 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1836 | 0.020 |
Why?
| | Inflammation | 1 | 2016 | 2515 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 3956 | 0.020 |
Why?
| | Adolescent | 1 | 2020 | 18219 | 0.010 |
Why?
|
|
Vanderlinden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|